Pharmaniaga Lyzorca 75mg

Manufacturer
Idaman Pharma Manufacturing Sdn Bhd

Registration Number
MAL23046023AZ

Content
75 /mg of Pregabalin,

Indication
Lyzorca (Pregabalin) in 75 /mg capsule form is indicated for management of neuropathic pain, including diabetic neuropathy and post-herpetic neuralgia; treatment of fibromyalgia; as an adjunct for epilepsy; and for generalized anxiety disorder (GAD) depending on dose and clinical judgment

Instruction

• Recommended starting dose is 75 /mg twice daily (i.e. 150 /mg/day) in the management of neuropathic pain or anxiety, with potential up-titration to 300 /mg/day or more according to response and tolerability, up to max 600 /mg/day in divided doses 

• It may be taken with or without food.

• If discontinuing treatment, taper gradually over at least one week to minimize withdrawal symptoms